Načítá se...
Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy
BACKGROUND: The intake of soy isoflavones among women with breast cancer has become a public health concern, because these compounds have weak estrogenic effects. There is little clinical evidence about their safety for patients with breast cancer who are receiving adjuvant endocrine therapy. METHOD...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Canadian Medical Association
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2988534/ https://ncbi.nlm.nih.gov/pubmed/20956506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/cmaj.091298 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|